About AMPA Biosciences
Vision & Mission:
Vision: To reduce cancer mortality through early, accessible, and accurate detection.
Mission: We develop cutting-edge diagnostic tools that detect cancer before symptoms appear, improving outcomes and saving lives.


Company overview:
AMPA Biosciences, Inc. is a cutting‑edge diagnostics company focused on inventing, developing, and manufacturing advanced in vitro testing solutions for oncology and other critical diseases. Our mission is to enable early cancer detection, support oncology diagnostics decision-making, and power real‑time disease monitoring—through proprietary platforms and laboratory services tailored for precision medicine.
Founded by scientists and technologists with deep expertise in molecular diagnostics, bioengineering, and clinical oncology, AMPA Biosciences combines innovative assay design with scalable manufacturing processes. We deliver comprehensive solutions ranging from screening tests to companion diagnostics and longitudinal monitoring assays, empowering clinicians and patients with timely, actionable insights.
At AMPA, quality and reliability are non-negotiable: our assays are rigorously validated to meet clinical and regulatory standards, and our lab services adhere to strict accreditation protocols. Looking ahead, we’re committed to expanding our product pipeline and service capabilities—driving earlier intervention, better treatment outcomes, and a new standard of care in disease management.
Our Location
Located at the forefront of biotechnology, we are dedicated to advancing diagnostics for oncology and other diseases to improve patient outcomes.
Address
101 College St. New Haven, CT, USA
Hours
9 AM - 5 PM
Contact Us
Reach out for inquiries about our innovative diagnostic solutions.